Publication | Closed Access
46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)
36
Citations
0
References
2004
Year
HepatologyViral HepatitisLong Term SafetyYear StudyHepatitis BHepatitisAntiviral TherapyPharmacotherapyLiver DiseaseAdefovir DipivoxilMedicine
No additional data available for this publication yet. Check back later!